203 related articles for article (PubMed ID: 31628803)
1. Prospective evaluation of ventricular assist device risk scores' capacity to predict cardiopulmonary exercise parameters.
Dorken Gallastegi A; Öztürk P; Demir E; Engin Ç; Nalbantgil S; Yağdı T; Özbaran M
Interact Cardiovasc Thorac Surg; 2020 Feb; 30(2):223-228. PubMed ID: 31628803
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Cardiopulmonary Exercise Test Parameters in Ventricular Assist Device Therapy.
Dorken Gallastegi A; Ergi GD; Kahraman Ü; Yağmur B; Çinar E; Karapolat H; Nalbantgil S; Engin Ç; Yağdi T; Özbaran M
ASAIO J; 2022 Jun; 68(6):808-813. PubMed ID: 34494984
[TBL] [Abstract][Full Text] [Related]
3. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
[TBL] [Abstract][Full Text] [Related]
4. Exercise capacity following ventricular assist device implantation via thoracotomy with outflow cannula anastomosis to the descending aorta.
Dorken Gallastegi A; Kahraman Ü; Yağmur B; Çınar E; Nalbantgil S; Engin Ç; Yağdı T; Özbaran M
Artif Organs; 2021 Nov; 45(11):1317-1327. PubMed ID: 34153119
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Improvement in Cardiopulmonary Exercise Testing After Left Ventricular Assist Device Implantation.
Rosenbaum AN; Dunlay SM; Pereira NL; Allison TG; Maltais S; Stulak JM; Joyce LD; Kushwaha SS
ASAIO J; 2018; 64(5):610-615. PubMed ID: 29045277
[TBL] [Abstract][Full Text] [Related]
6. Changes in cardiopulmonary exercise testing parameters following continuous flow left ventricular assist device implantation and heart transplantation.
Dunlay SM; Allison TG; Pereira NL
J Card Fail; 2014 Aug; 20(8):548-54. PubMed ID: 24893345
[TBL] [Abstract][Full Text] [Related]
7. Pre-operative mortality risk assessment in patients with continuous-flow left ventricular assist devices: application of the HeartMate II risk score.
Thomas SS; Nahumi N; Han J; Lippel M; Colombo P; Yuzefpolskaya M; Takayama H; Naka Y; Uriel N; Jorde UP
J Heart Lung Transplant; 2014 Jul; 33(7):675-81. PubMed ID: 24726424
[TBL] [Abstract][Full Text] [Related]
8. Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy.
Compostella L; Russo N; Setzu T; Compostella C; Bellotto F
Artif Organs; 2014 May; 38(5):366-73. PubMed ID: 24117945
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.
Deo SV; Daly RC; Altarabsheh SE; Hasin T; Zhao Y; Shah IK; Stulak JM; Boilson BA; Schirger JA; Joyce LD; Park SJ
ASAIO J; 2013; 59(1):57-62. PubMed ID: 23263341
[TBL] [Abstract][Full Text] [Related]
10. Lvad pump speed increase is associated with increased peak exercise cardiac output and vo
Vignati C; Apostolo A; Cattadori G; Farina S; Del Torto A; Scuri S; Gerosa G; Bottio T; Tarzia V; Bejko J; Sisillo E; Nicoli F; Sciomer S; Alamanni F; Paolillo S; Agostoni P
Int J Cardiol; 2017 Mar; 230():28-32. PubMed ID: 28038810
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular assist devices improve functional class without normalizing peak oxygen consumption.
Benton CR; Sayer G; Nair AP; Ashley K; Domanski MJ; Henzlova MJ; Anyanwu AC; Pinney SP
ASAIO J; 2015; 61(3):237-43. PubMed ID: 25635934
[TBL] [Abstract][Full Text] [Related]
12. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting?
de Jonge N; Kirkels H; Lahpor JR; Klöpping C; Hulzebos EJ; de la Rivière AB; Robles de Medina EO
J Am Coll Cardiol; 2001 Jun; 37(7):1794-9. PubMed ID: 11401113
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Peak Oxygen Uptake in Patients Supported With Left Ventricular Assist Devices (PRO-VAD).
Mirza KK; Szymanski MK; Schmidt T; de Jonge N; Brahmbhatt DH; Billia F; Hsu S; MacGowan GA; Jakovljevic DG; Agostoni P; Trombara F; Jorde U; Rochlani Y; Vandersmissen K; Reiss N; Russell SD; Meyns B; Gustafsson F;
JACC Heart Fail; 2021 Oct; 9(10):758-767. PubMed ID: 34391745
[TBL] [Abstract][Full Text] [Related]
14. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
[TBL] [Abstract][Full Text] [Related]
15. Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.
Paolillo S; Veglia F; Salvioni E; Corrà U; Piepoli M; Lagioia R; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Metra M; Senni M; Bonomi A; Scrutinio D; Raimondo R; Emdin M; Magrì D; Parati G; Re F; Cicoira M; Minà C; Correale M; Frigerio M; Bussotti M; Battaia E; Guazzi M; Badagliacca R; Di Lenarda A; Maggioni A; Passino C; Sciomer S; Pacileo G; Mapelli M; Vignati C; Clemenza F; Binno S; Lombardi C; Filardi PP; Agostoni P;
Eur J Heart Fail; 2019 Feb; 21(2):208-217. PubMed ID: 30632680
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic Response to Exercise in Patients Supported by Continuous Flow Left Ventricular Assist Devices.
Moss N; Rakita V; Lala A; Parikh A; Roldan J; Mitter SS; Anyanwu A; Campoli M; Burkhoff D; Mancini DM
JACC Heart Fail; 2020 Apr; 8(4):291-301. PubMed ID: 32035893
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.
Nadruz W; West E; Sengeløv M; Santos M; Groarke JD; Forman DE; Claggett B; Skali H; Shah AM
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089342
[TBL] [Abstract][Full Text] [Related]
18. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
[TBL] [Abstract][Full Text] [Related]
19. VE/VCO2 slope predicts RV dysfunction and mortality after left ventricular assist device: a fresh look at cardiopulmonary stress testing for prognostication.
Grinstein J; Sawalha Y; Medvedofsky DA; Ahmad S; Hofmeyer M; Rodrigo M; Kadakkal A; Barnett C; Kalantari S; Talati I; Zaghol R; Molina EJ; Sheikh FH; Najjar SS
J Artif Organs; 2021 Dec; 24(4):425-432. PubMed ID: 33792816
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of a new cardiopulmonary exercise testing parameter in chronic heart failure: oxygen uptake efficiency at peak exercise - comparison with oxygen uptake efficiency slope.
Toste A; Soares R; Feliciano J; Andreozzi V; Silva S; Abreu A; Ramos R; Santos N; Ferreira L; Ferreira RC
Rev Port Cardiol; 2011 Oct; 30(10):781-7. PubMed ID: 22118129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
